Topics

Biologics, Proteins, Vaccines | Biosimilars

Are Biotech Companies Strong Investments?

Biotech capital raised via IPO has increased dramatically over the past couple of years.
Jason Monteleone , CEO, Clinipace 05.07.19
Biologics, Proteins, Vaccines

The Coming Revolution of Personalized Medicine

Cell and gene therapy is creating a momentous shift in the pharma landscape and reshaping the future of medicine.
Tommy Fanning, Global Head Biopharmaceuticals, IDA Ireland 05.07.19
The Modern CDMO

Flexibility, collaboration and innovation are hallmark traits of today’s successful contract service organizations.
Paul Quigley, Head of Drug Substance, Arcinova 05.07.19
R&D

Top Pharma & Biopharma R&D Spend

A by the numbers look at the industry
Infographics
Breaking News | Collaborations & Alliances | Industry News

Alvogen Investment Bolsters Asian Presence

Enters cross-investment partnership with Fuji to enhance market access to fast-growing Asian pharma market
03.21.19
2019 Contract Manufacturing Industry Survey

We polled our readers to gain insight about their impressions of working with contract manufacturers.
03.06.19
2019 Trends & Predictions

Looking to the year ahead we discuss six key trends that will shape the industry.
David Hukin and Thomas Underwood, QVigilance and Quanticate 03.06.19
Biologics, Proteins, Vaccines

Preparing For Your CDMO Selection Process

Five questions that must be answered before starting your CDMO search.
Ajinomoto Bio-Pharma Services 03.06.19
CDMO Market Trends

Vivek Sharma, CEO, Piramal Pharma Solutions, discusses outsourcing trends, opportunities, and the capabilities needed for today’s (bio)pharma pipelines.
Kristin Brooks, Managing Editor, Contract Pharma 03.06.19
Breaking News | Industry News

Hovione Set for Production Capacity Expansion

CDMO issues $50 million bond to fuel growth plans
01.30.19
Stock Perfomance for Top Pharma & Biopharma

Major acquisitions impact share prices in 2018
Infographics
Dedicated to Excellence

Cambrex’s Shawn Cavanagh talks operational excellence and what it means to the CDMO.
Tim Wright, Editor, Contract Pharma 11.13.18
Playing BIG

What does it take to acquire products from global pharma companies?
Dr. Christoph Bieri, Managing Partner, Kurmann Partners AG 11.13.18
Decoding Company Culture: The Key to a Long Term Fit

Having shared and aligned values is critical to success in the workplace.
Ryan Raver, PhD w/David G. Jensen 06.12.18
Breaking News | Industry News

Alcami Acquired by Private Equity Firm

The CDMO's management team will remain in place
06.01.18
Opportunities to Lower Drug Prices and Improve Affordability

From creation (manufacturing) to consumption (patient)
Girish Malhotra, Contributing Editor 05.08.18
Analytical Services | QA/QC

Newsmakers: LSNE

LSNE Expands Capabilities and QC Laboratory Space
Tim Wright, Editor 05.08.18
Biologics, Proteins, Vaccines

Newsmakers: Lonza Pharma & Biotech

CDMO Industry Growth Continues
Betsy Louda, Associate Editor 05.08.18
R&D

A Blueprint to Unify Clinical Operations

Fast-growing clinical research organization speeds study execution and improves quality
Jim Reilly, VP of Clinical Market Strategy, Veeva Systems 05.08.18
Rising CMO Business Fortunes

Several indicators spurring revenue growth for contract manufacturing industry
Adam Runsdorf, President, WDPrx – Woodfield Pharmaceutical, LLC 05.08.18